NCT04804956View on ClinicalTrials.gov

Mesorectal Microbiome as a Prognostic Factor in Patients With Rectal Cancer

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2026

Conditions
Rectal Cancer
Interventions
PROCEDURE

Stool sample

One stool sample will be taken at baseline for microbiota characterization

PROCEDURE

Rectal mucosa sample

Characterization of tissue microbiota before and after surgery.

PROCEDURE

Mesorectal adipose tissue sample

Characterization of tissue microbiota and dysfunction

PROCEDURE

Subcutaneous adipose tissue sample

Characterization of tissue microbiota and dysfunction

PROCEDURE

Visceral adipose tissue sample

Characterization of tissue microbiota and dysfunction

BEHAVIORAL

Dietary assessment

Dietary assessment will be taken at baseline

Trial Locations (1)

17007

RECRUITING

Hospital Universitari Dr. Josep Trueta de Girona, Girona

Sponsors
All Listed Sponsors
collaborator

Girona Biomedical Research Institute

UNKNOWN

lead

University Hospital of Girona Dr. Josep Trueta

NETWORK

NCT04804956 - Mesorectal Microbiome as a Prognostic Factor in Patients With Rectal Cancer | Biotech Hunter | Biotech Hunter